Showing 52,221 - 52,240 results of 226,405 for search '(( a ((((a decrease) OR (larger decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.72s Refine Results
  1. 52221

    Sugar-Based Gemini Surfactants with Peptide BondsSynthesis, Adsorption, Micellization, and Biodegradability by Tomokazu Yoshimura (2070670)

    Published 2005
    “…The adsorption and micellization properties of C<i><sub>n</sub></i>peLac and 2C<i><sub>n</sub></i>peLac were characterized by the measurement of their equilibrium and dynamic surface tension, steady-state fluorescence using pyrene as a probe, dynamic light scattering (DLS), and time-resolved fluorescence quenching (TRFQ), and their biodegradability was also investigated. …”
  2. 52222

    XTH43-RNAi impairs <i>H</i>. <i>glycines</i> parasitism, revealed by the female index (FI). by Prakash M. Niraula (6816713)

    Published 2021
    “…<p><b>A</b>. <i>G</i>. <i>max</i> plant (left panel) prior to genetic engineering. …”
  3. 52223
  4. 52224
  5. 52225

    Variations of the ratio of rework and regular production rates (<i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub>) and their effects on the expected system cost E[<i>TCU</i>(<i>T*</i>, <i>n*</i>)], which shows that as <i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub> decreases below a turning point 0.5, the expected system cost begins to increase significantly by Singa Wang Chiu (3383579)

    Published 2016
    “…<p>Variations of the ratio of rework and regular production rates (<i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub>) and their effects on the expected system cost E[<i>TCU</i>(<i>T*</i>, <i>n*</i>)], which shows that as <i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub> decreases below a turning point 0.5, the expected system cost begins to increase significantly</p>…”
  6. 52226
  7. 52227
  8. 52228
  9. 52229
  10. 52230
  11. 52231
  12. 52232
  13. 52233

    Supplementary Material for: A case report: Metastatic Gestational Trophoblastic Neoplasia leading to acute respiratory failure and death. About a particularly challenging managemen... by figshare admin karger (2628495)

    Published 2025
    “…In third-line, Pembrolizumab was used, and the patient experienced a significant decrease in HCG. However, due to hematologic toxicity, we discontinued the treatment. …”
  14. 52234
  15. 52235
  16. 52236

    Data_Sheet_1_A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis... by Christian Dejaco (12618)

    Published 2022
    “…Mean age was 50.2 ± 14.2 years; 64% were female. Disease activity decreased from baseline to month 24 (RA: CDAI −24.3 ± 13.5; axSpA: BASDAI −4.4 ± 2.1, and PsA: CDAI −21.7 ± 8.5, p < 0.0001, each). …”
  17. 52237

    Data_Sheet_2_A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis... by Christian Dejaco (12618)

    Published 2022
    “…Mean age was 50.2 ± 14.2 years; 64% were female. Disease activity decreased from baseline to month 24 (RA: CDAI −24.3 ± 13.5; axSpA: BASDAI −4.4 ± 2.1, and PsA: CDAI −21.7 ± 8.5, p < 0.0001, each). …”
  18. 52238
  19. 52239
  20. 52240